U.S. Mortgage Finance Stock News

In August 2026, Absci Corporation reported positive interim Phase 1 data from its HEADLINETM trial of ABS-201 for pattern hair loss, indicating a favorable safety profile and an estimated half-life of at least 65 days, while also reaffirming plans to advance the program into endometriosis and a Phase 2 trial in 2026. These early results suggest ABS-201 could offer infrequent dosing and a differentiated, non-sex-steroid approach in two large, under-served indications, alongside emerging...

Why Middleby’s latest earnings are getting attention Middleby (MIDD) has drawn fresh attention after reporting second quarter and six month results that showed higher sales alongside sharply lower net income, paired with new guidance following the Food Processing spin off. The company reported second quarter sales of US$875.55 million compared with US$796.80 million a year earlier. Net income for the quarter was US$54.81 million compared with US$105.96 million in the prior year period. See...

In August 2026, NVIDIA Corporation announced memorandums of understanding with KKR & Co. Inc. and five other major financial institutions to create independent compute financing platforms, aiming to mobilize over US$500 billion of third-party capital for AI infrastructure across its ecosystem, subject to final agreements. This move positions KKR as an important capital partner in AI infrastructure financing, aligning its private markets expertise with rising demand for large-scale compute...

National Health Investors, Inc. reported second-quarter 2026 results showing year-on-year increases in sales to US$71.39 million, revenue to US$121.32 million, and net income to US$55.67 million, alongside higher earnings per share from continuing operations. Reinforcing these stronger earnings, the company’s board also approved a quarterly dividend increase to US$0.94 per share, signaling management’s confidence in cash flow durability and capital allocation priorities. We’ll now examine...

Dell Technologies (DELL) is back in focus after investors reacted to a cluster of AI driven catalysts, including a record AI backlog, stronger demand across core hardware segments, and a renewed Alienware partnership with Team Liquid. See our latest analysis for Dell Technologies. Dell Technologies' share price has been volatile around AI related headlines, with a sharp 90 day share price return of 49.76% and a very large 5 year total shareholder return that signals strong long term momentum...

In August 2026, VinFast Auto introduced an Energy Cost Saving calculator for U.S. buyers, reported strong year-to-date EV deliveries in Vietnam, and continued building manufacturing hubs in India and Indonesia to support future exports. Together, these developments highlight VinFast’s focus on explaining total cost of ownership to consumers while scaling a geographically diversified production base and reinforcing its domestic market position. Now we’ll explore how VinFast’s new Energy Cost...

Permian Basin Royalty Trust recently declared a reduced cash distribution of US$0.018701 per unit for September 15, 2026, reflecting the absence of a prior settlement payment and weaker contributions from Texas Royalty Properties. Despite the lower payout, the trust’s latest quarterly report showed higher year-over-year revenue and net income, highlighting how commodity mix and one-off items can sharply influence monthly distributions. We’ll now examine how the reduced monthly...

Fresh interest in EOG Resources (EOG) has been driven by recent coverage highlighting its value metrics, earnings estimate revisions and history of strong returns. This has prompted many investors to reassess the stock’s current pricing. See our latest analysis for EOG Resources. Recent share price moves suggest momentum is building for EOG Resources, with a 7 day share price return of 7.32% and a year to date share price return of 42.68%. The 5 year total shareholder return of 178.34%...

In August 2026, Lowe's Companies reported second-quarter sales of US$25,956 million with flat earnings per share, and subsequently reduced its full-year 2026 guidance to US$92.0 billion in sales, an 11.2% operating margin, and about US$11.75 in diluted EPS. The combination of higher year-on-year sales but essentially unchanged profitability, alongside tighter full-year targets, highlights management’s caution around consumer demand and discretionary home improvement spending. Next, we’ll...

UroGen Pharma (URGN) drew fresh investor attention after submitting a New Drug Application to the FDA for UGN-103, supported by Phase 3 UTOPIA trial data in recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. See our latest analysis for UroGen Pharma. The NDA news lands after a strong run for UroGen Pharma, with a 30-day share price return of 14.38%, a 90-day share price return of 62.20%, and a 1-year total shareholder return of 141.05% that signals building momentum...

Liquidia Corporation recently reported past second-quarter 2026 results showing revenue of US$171.68 million versus US$8.84 million a year earlier, with net income of US$74.72 million replacing a prior net loss and basic earnings per share from continuing operations rising to US$0.84. Over the first half of 2026, this shift from losses to profits and strong revenue expansion underscores how YUTREPIA’s commercialization and improved payer access are now translating more fully into the...

Deluxe (DLX) is back in focus after appointing Kevin Jones as President of its Merchant Services division, shortly after acquiring his company Celero Commerce. This acquisition helped position Deluxe as a top-10 non-bank merchant acquirer. See our latest analysis for Deluxe. Investors have seen Deluxe’s share price give back some ground recently, with a 1-month share price return that declined 9.26% and a 7-day share price return that declined 1.83%. However, the year-to-date share price...

Align Technology (ALGN) continues to draw investor attention after recent share price moves, with the stock last closing at $162.55. The company reported annual revenue of $4.14b and net income of $413.58m. See our latest analysis for Align Technology. Recent trading has been choppy for Align Technology, with a 1-day share price return of 2.27% following a 7-day share price decline of 10.35%, while the 1-year total shareholder return of 8.68% contrasts with a 3-year total shareholder return...

With US and Canada trade talks breaking down and fresh tariffs set to hit everything from steel to farm gear, investors are staring at a reshaped playing field where cross border supply chains may face higher costs and fresh uncertainty. That kind of disruption can punish some stocks yet open doors for others that lean on domestic production. This article walks through three stocks exposed to the latest tariff news and explains how they might fit into your watchlist. The stocks highlighted...

Westinghouse Air Brake Technologies (WAB) is back in focus after reporting quarterly earnings that exceeded expectations. The results were supported by higher sales and improved operating margins, and the company also raised full-year guidance for adjusted earnings and revenues. See our latest analysis for Westinghouse Air Brake Technologies. That earnings surprise lands on top of a strong run for Westinghouse Air Brake Technologies, with a 16.05% 90 day share price return and a 37.59% year...

Microchip Technology has delivered a 17.0% gain year to date, yet the stock now screens as expensive, with both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples pointing to a premium price tag. For investors, that combination raises the question of how much of the company’s recent product progress in areas like space grade timing and edge AI connectivity is already reflected in the share price. The 17.0% year to date return can signal growing optimism around...

Nucleai recently announced an ongoing translational research collaboration with Gilead Sciences, using AI-driven tissue analytics on large H&E and IHC slide datasets to support Gilead’s global antibody-drug conjugate clinical development programs across multiple oncology indications. The work has already produced candidate spatial biomarkers and fresh biological insights, highlighting how AI-native tissue intelligence could help standardize biomarker assessment and better link tumor biology...

WEX (WEX) shares were in focus after the company reported second quarter 2026 results that beat earnings and revenue estimates, raised full year guidance, and outlined plans to prioritize share repurchases. See our latest analysis for WEX. WEX shares trade at US$199.93, with a 1-month share price return of 13.5% and a 90-day share price return of 32.8%, while the 1-year total shareholder return sits at 15.6%, indicating recent positive momentum following earnings and guidance. If strong...

Packaging Corporation of America (PKG) drew fresh investor attention after reporting second quarter 2026 adjusted earnings above consensus, supported by higher production, stronger sales volumes, and contributions from its recent Greif acquisition. See our latest analysis for Packaging Corporation of America. Packaging Corporation of America’s recent earnings beat and Greif integration come after a strong run, with a 19.74% year to date share price return and a 93.51% five year total...

Kahn Swick & Foti, LLC recently continued its investigation into The Scotts Miracle-Gro Company over potential fiduciary breaches after 2023 results revealed a 6% sales decline, a 420 basis point gross margin reduction, a 25% cut to full-year EBITDA guidance, and a US$20,000,000 inventory write-down. These disclosures have already led to a securities class action lawsuit alleging failures to share material information, putting Scotts Miracle-Gro’s governance, disclosure practices, and risk...

With a fresh US–Canada trade clash pushing tariffs higher and rattling cross border supply chains, investors face a new map of potential winners and losers. Sudden shifts in costs and sourcing can reshape where production happens and which companies keep pricing power. This article walks through three stocks from our U.S. Onshoring and Domestic Manufacturing Beneficiaries screener that appear well positioned for this moment. The stocks highlighted below are just a starting sample, and the...

Omeros (OMER) is in focus after reporting a shift to net income in its second quarter and first half of 2026, replacing prior year losses and prompting fresh attention on the stock. See our latest analysis for Omeros. That shift to profit has coincided with sharp share price momentum for Omeros, with a 96.83% 1 month share price return and a 68.15% 3 month share price return. This has contributed to a very large 1 year total shareholder return. If strong recent gains in Omeros have you...

Why Illumina’s New Financing Matters For Stock Investors Illumina (ILMN) has just put in place a new US$1b senior unsecured revolving credit facility and completed a roughly US$300m fixed income offering. These financing steps give investors fresh information on the company’s balance sheet flexibility. The new credit agreement runs for five years, with options to extend to 2031. It replaces Illumina’s prior facility that was terminated on 13 August 2026. As of that date, the company reported...

CME Group has moved to broaden its derivatives line-up, introducing index-based Hockey futures, AI compute rental futures tied to GPU costs, and 24/7 trading for its 100‑Ounce Silver contract, alongside previously launched 1‑Ounce Gold weekend trading. Together, these launches extend CME’s reach into sports, AI infrastructure, and retail-friendly precious metals trading, highlighting how exchange-style risk management is being applied to increasingly unconventional underlying markets. We’ll...